ERIMOS PHARMACEUTICALS LLC has a total of 40 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AMGEN EUROPE GMBH, INST MEDIZINTECHNOLOGIE MAGDEB and DALTON JAMES T.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | United States | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Australia | 5 | |
#6 | Hong Kong | 4 | |
#7 | Canada | 2 | |
#8 | Mexico | 2 | |
#9 | Republic of Korea | 1 |
# | Name | Total Patents |
---|---|---|
#1 | Heller Jonathan Daniel | 18 |
#2 | Lopez Rocio Alejandra | 18 |
#3 | Rhodes Melissa Claire | 14 |
#4 | Blomberg Jessica Andrea Loduca | 14 |
#5 | Chen Qingqi | 9 |
#6 | Morris Amanda Jean | 9 |
#7 | Frazer Neil | 8 |
#8 | Lopez Rocio A | 8 |
#9 | Heller Jonathan D | 8 |
#10 | Goodman Amanda Beth | 8 |
Publication | Filing date | Title |
---|---|---|
US2010093872A1 | Stable aqueous formulations of water insoluble or poorly soluble drugs | |
CN102171173A | Scalable synthetic process for making meso-1,4 - bis (3,4 - dimethoxyphenyl)-dimethyl butane | |
CN101389319A | Methods of treating influenza viral infections | |
KR20090006062A | Methods of treating influenza viral infections | |
CN101150955A | Oral formulations for delivery of catecholic butanes including NDGA compounds | |
US2008096967A1 | Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into Animals | |
US2006141029A1 | Methods and compositions for delivery of catecholic butanes for treatment of diseases | |
US2006141025A1 | Methods for delivery of catecholic butanes for treatment of tumors |